GLP-1 drug adoption among U.S. adults hit 13.1% in June 2026, and a new pill form of the medication is expected to drive that number significantly higher. Analysts project the broader adoption could cost the grocery industry more than $20 billion as users of the appetite-suppressing drugs consistently buy less food overall.
This is a macro demand story with direct relevance to produce. GLP-1 users are known to reduce overall food intake, but research has generally shown they still prioritize fresh, nutrient-dense foods — which could mean produce holds up better than center-store packaged goods. The grocery industry impact, however, is real and growing.
For produce category managers and salespeople, this is worth monitoring as a background force shaping grocery volume trends heading into the back half of 2026. If overall basket sizes shrink industry-wide, the battle for shelf space and promotional investment will intensify.